Possible anti-metastatic effect of iloprost in a patient with systemic sclerosis with lung cancer: a case study.
Rheumatol Int
; 32(5): 1437-41, 2012 May.
Article
in En
| MEDLINE
| ID: mdl-21448647
Full text:
1
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Vasodilator Agents
/
Adenocarcinoma
/
Iloprost
/
Hypertension, Pulmonary
/
Lung Neoplasms
/
Antihypertensive Agents
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Year:
2012
Type:
Article